Skip to main content
Features
Integrations
Data
Pricing
Log In
Start Free Trial
Features
Integrations
Data
Pricing
Log In
Start Free Trial
Salvatore Ribisi
Sign up to set email alerts
73
Publications
47
Citation Statements Received
317
Citation Statements Given
How they've been cited
84
1
46
0
How they cite others
371
14
303
0
Affiliations
Candiolo Cancer Institute
,
Istituti di Ricovero e Cura a Carattere Scientifico
Publications
Order By: Most citations
Personalized therapeutic strategies in HER2-driven gastric cancer
Ughetto
1
,
Migliore
2
,
Pietrantonio
3
et al.
2021
Gastric Cancer
Abstract
Show
22
1
15
0
Get access via publisher
Add to collection
Cite
BRCA2
Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
Petrelli
1
,
Rizzolio
2
,
Pietrantonio
3
et al.
2023
Abstract
Show
22
0
12
0
Get access via publisher
Add to collection
Cite
RAIN Is a Novel Enhancer-Associated lncRNA That Controls RUNX2 Expression and Promotes Breast and Thyroid Cancer
Rossi
1
,
Pistoni
2
,
Sancisi
3
et al.
2020
Abstract
Show
27
0
10
0
Get access via publisher
Add to collection
Cite
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer
Petrelli
1
,
Bellomo
2
,
Sarotto
3
et al.
2020
ESMO Open
Abstract
Show
13
0
9
0
Get access via publisher
Add to collection
Cite
Figure S4 from <i>BRCA2</i> Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
Petrelli
1
,
Rizzolio
2
,
Pietrantonio
3
et al.
2023
Preprint
Abstract
Show
0
0
0
0
Get access via publisher
Add to collection
Cite
Data from <i>BRCA2</i> Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
Petrelli
1
,
Rizzolio
2
,
Pietrantonio
3
et al.
2023
Preprint
Abstract
Show
0
0
0
0
Get access via publisher
Add to collection
Cite
Figure S6 from <i>BRCA2</i> Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
Petrelli
1
,
Rizzolio
2
,
Pietrantonio
3
et al.
2023
Preprint
Abstract
Show
0
0
0
0
Get access via publisher
Add to collection
Cite
Figure S3 from <i>BRCA2</i> Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors
Petrelli
1
,
Rizzolio
2
,
Pietrantonio
3
et al.
2023
Preprint
Abstract
Show
0
0
0
0
Get access via publisher
Add to collection
Cite
1
2
3
4
5
6
